Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Bique AM et al. | 2016 | intact cell/cell culture, MC3T3-E1 cells (mouse osteoblast-like cell line) and SaOS-2 (cell line derived from human osteosarcoma) | magnetic field, 50/60 Hz | 1 mT |
Supino R et al. | 2001 | intact cell/cell culture, MCF-7 (breast cancer cell line) and normal fibroblasts | magnetic field, 50/60 Hz | 20–500 µT |
Girgert R et al. | 2005 | intact cell/cell culture, MCF-7 (breast cancer cell line); MCF-7 clones (MCF-7 p181 and MCF-7 p40) | magnetic field, 50/60 Hz, co-exposure | 200 nT–100 µT |
Blackman CF et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz | 1.2 µT |
Ding GR et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
Dees C et al. | 1996 | intact cell/cell culture, MCF-7 and T-47D cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz, co-exposure | 1.2–900 µT |
Harland JD et al. | 1997 | intact cell/cell culture, MCF-7 cells (human breast cancer cell line) | magnetic field, 50/60 Hz | 0.2–1.2 µT |
Harland J et al. | 1999 | intact cell/cell culture, MCF-7 cells (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 0.2–1.2 µT |
Liburdy RP et al. | 1993 | intact cell/cell culture, MCF-7 cells (melatonin-sensitive breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 0.19–1.195 µT |
Loberg LI et al. | 2000 | intact cell/cell culture, MCF-7, ZR-75-1, T-47D, and MDA-MB-231 (breast cancer cell line) and normal human breast epithalial cells | magnetic field, 50/60 Hz | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.